Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Tivozanib + Gemcitabine in Metastatic RCC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
- Status
- TERMINATED
- Phase
- PHASE1
Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
- Status
- COMPLETED
- Phase
- PHASE2
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
- Status
- WITHDRAWN
- Phase
- N/A
Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical and Histopathologic Characteristics of BAP1 Mutations
- Status
- COMPLETED
- Phase
- N/A
Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy
- Status
- TERMINATED
- Phase
- NA
REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT
- Status
- WITHDRAWN
- Phase
- PHASE3
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy
- Status
- TERMINATED
- Phase
- PHASE2
Sunitinib Drug Levels and Outcomes in Kidney Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Imaging Correlates of Renal Cell Carcinoma Biological Features
- Status
- COMPLETED
- Phase
- NA
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
CRLX101 Plus Bevacizumab in Advanced RCC
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)
- Status
- COMPLETED
- Phase
- PHASE3